Skip to main content

Cardio-oncology Related to Heart Failure, An Issue of Heart Failure Clinics

  • 1st Edition, Volume 7-3 - July 28, 2011
  • Authors: Daniel J. Lenihan, Douglas B. Sawyer
  • Language: English
  • Hardback ISBN:
    9 7 8 - 1 - 4 5 5 7 - 1 1 0 1 - 7

As the number of effective anti-neoplastic agents has grown, there has been a concomitant increase in side effects.  Cardiotoxicity, and specifically LV dysfunction, remains the… Read more

Cardio-oncology Related to Heart Failure, An Issue of Heart Failure Clinics

Purchase options

LIMITED OFFER

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code is needed.

Institutional subscription on ScienceDirect

Request a sales quote
As the number of effective anti-neoplastic agents has grown, there has been a concomitant increase in side effects.  Cardiotoxicity, and specifically LV dysfunction, remains the limiting factor for many such agents, and is the focus of growing research and clinical emphasis.  This issue summarizes for the heart failure specialist the possible ways that chemotherapeutic agents might cause cardiotoxicity as well as the methods for detecting, treating and preventing cardiotoxicity.